Compare Tango Therapeutics Inc. (TNGX) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Wix.Com Ltd — how do they compare? Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B), while Wix.Com Ltd trades at $74 (market cap $3.00B). The key difference: Tango Therapeutics Inc. is the larger of the two by market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and Wix.Com Ltd for 62 Days on average.
| TNGX | WIX | |
|---|---|---|
Market Cap | $3.75B | $3.00B |
Volume | 9,619,106 | 960,938 |
Sector | Health | Technology |
52-Week High | $32.90 | $145.54 |
52-Week Low | $7.50 | $40.43 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $2.77B | $4.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
WIX trades at $74.31, up 0.18% on the day, with a bearish technical signal from moving averages but neutral oscillators. Revenue growth is strong, reaching $1.99B in 2025, though net income margin turned negative at -8.19% in 2026. The company faces multiple class-action lawsuits filed in September 2026, adding legal overhangs. Analyst consensus remains bullish with a $77.00 price target, but negative equity and volatile cash flows highlight financial instability.
The outlook is mixed: robust revenue growth and analyst support offer upside, but profitability challenges, negative equity, and legal risks pose significant headwinds. Investors should weigh the high P/E of 62.84 against earnings volatility and litigation uncertainties before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
